AI assistant
Sending…
PERRIGO Co plc — Director's Dealing 2019
Oct 10, 2019
31387_dirs_2019-10-10_dc909fcc-fd1a-48b6-ac01-1eae2318c0bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERRIGO Co plc (PRGO)
CIK: 0001585364
Period of Report: 2019-10-08
Reporting Person: Quinn Grainne (EVP, Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-08 | Ordinary Shares | M | 5011 | $51.94 | Acquired | 7704 | Direct |
| 2019-10-08 | Ordinary Shares | F | 2606 | $51.94 | Disposed | 5098 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-10-08 | Restricted Stock Units | $ | M | 5011 | Disposed | 2019-10-08 | Ordinary Shares (5011.0) | Direct |
Footnotes
F1: Vesting of service-based restricted stock units granted on October 8, 2018.
F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
More from PERRIGO Co plc
Earnings Release
2026
May 6
Regulatory Filings
2026
May 5
Transaction in Own Shares
2026
May 5
Share Issue/Capital Change
2026
May 5
Share Issue/Capital Change
2026
May 5
Regulatory Filings
2026
May 5
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20